Hengqiao Shen

机构：China Pharmaceutical University, Zhejiang Yongning Pharma (China)

发表论文 4 篇 · 总被引 56 次 · h-index 4

代表论文

• Discovery of a Silicon-Containing Pan-Genotype Hepatitis C Virus NS5A Inhibitor (2020 · Journal of Medicinal Chemistry · 被引 32)
• Design, synthesis and identification of silicon-containing HCV NS5A inhibitors with pan-genotype activity (2018 · European Journal of Medicinal Chemistry · 被引 9)
• Discovery of TQ-3959 as a Potent andOrally Bioavailable BTK PROTAC Degrader Incorporating a Novel Benzisoxazole-BasedCRBN Ligand for the Treatment of B-Cell Malignancies (2025 · Journal of Medicinal Chemistry · 被引 7)
• Design of a novel long-acting dual GLP-1/GIP receptor agonist (2024 · Bioorganic & Medicinal Chemistry · 被引 6)